P4107
[Leu31, Pro34]-Peptide YY
≥95%
Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Seleccione un Tamaño
0.5 MG
$151.50
$151.50
Precio de catálogo$303.00Ahorre 50 %En stockDetalles
Seleccione un Tamaño
Cambiar Vistas
0.5 MG
$151.50
About This Item
Fórmula empírica (notación de Hill):
C195H296N54O56
Peso molecular:
4292.76
Número MDL:
Código UNSPSC:
12352209
NACRES:
NA.32
$151.50
Precio de catálogo$303.00Ahorre 50 %En stockDetalles
Productos recomendados
Amino Acid Sequence
Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2
Acciones bioquímicas o fisiológicas
Agonist at Y1, Y4, and Y5 NPY receptors.
Código de clase de almacenamiento
11 - Combustible Solids
Clase de riesgo para el agua (WGK)
WGK 3
Punto de inflamabilidad (°F)
Not applicable
Punto de inflamabilidad (°C)
Not applicable
Equipo de protección personal
Eyeshields, Gloves, type N95 (US)
Elija entre una de las versiones más recientes:
¿Ya tiene este producto?
Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.
L Ferrier et al.
Gut, 46(3), 370-375 (2000-02-15)
Peptide YY (PYY) is involved in the regulation of several gut functions, including secretion and motility. It exerts its effects through a family of six receptors, commonly named the Y receptor family. To characterise the effects of PYY on strips
M Gobbi et al.
Journal of neurochemistry, 72(4), 1663-1670 (1999-03-31)
125I-[Leu31,Pro34]peptide YY (PYY) and 125I-PYY3-36, initially described as selective neuropeptide Y Y1 and Y2 receptor ligands, respectively, were recently shown to label also Y4 and Y5 receptors. We used receptor autoradiography to assess whether these ligands can be reliably used
Y Dumont et al.
Canadian journal of physiology and pharmacology, 78(2), 116-125 (2000-03-29)
We have evaluated 3 newly developed neuropeptide Y receptor antagonists in various in vitro binding and bioassays: BIBO3304 (Y1), T4[NPY33-36]4 (Y2), and CGP71683A (Y5). In rat brain homogenates, BIBO3304 competes for the same population of [125I][Leu31,Pro34] peptide YY (PYY) binding
Ross A Carson et al.
PloS one, 13(5), e0196387-e0196387 (2018-05-09)
Statins inhibit HMG-CoA reductase, the rate-limiting enzyme in the cholesterol biosynthesis pathway (CBP), and are used for the prevention of cardiovascular disease. The anti-inflammatory effects of statins may also provide therapeutic benefits and have led to their use in clinical
Xiaohong Yang et al.
Frontiers in bioengineering and biotechnology, 8, 468-468 (2020-06-18)
Effective clinical treatments of cartilage lesions in affected joints require large numbers of viable chondrogenic cells generated through in vivo stimulation or ex vivo expansion of chondrocytes isolated from small biopsy specimens. Conventional passaging of chondrocytes in culture provides sufficient
Active Filters
Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.
Póngase en contacto con el Servicio técnico
